Stock Investor Place - Critical Outcome Technologies Inc. COT.TX:TSX-V

<<Previous Profile Next Profile>> View All In This Industry View All Industries

Critical Outcome Technologies Inc.
Biotech
COT.TX : TSX-V

Critical Outcome Technologies Inc. (COTI) is helping the pharmaceutical industry get novel treatments to market faster.

At COTI’s core is a proprietary technology called CHEMSAS® that rapidly accelerates drug discovery. COTI is able to discover, profile, optimize, synthesize and validate novel compounds in 12-15 months. The current industry approach can take up to 60 months.

Our products are targeted libraries of novel, optimized lead compounds for the treatment of human diseases for which current therapy is either lacking or ineffective. Learn more about our pipeline.

IR Contact Name:	Michael Barr
Email Address:	mbarr@criticaloutcome.com
Phone Number:	519-858-5157
Fax Number:	N/A
Toll Free:	N/A
Website Address:	http://www.criticaloutcome.com

Stock Information:

Latest News Releases:

10/20 16:31	Critical Outcome Technologies Inc. Issues Stock Options to Employees
10/20 17:37	Critical Outcome Technologies Inc. Successfully Completes Critical Study
10/13 17:28	Critical Outcome Technologies Inc. Receives U.S. Patent for Promising Oncology Compound COTI-2
10/05 16:40	Critical Outcome Technologies Inc. Announces COTI-2 Scientific Results Accepted for Presentation at Influential Scientific Conference
9/28 16:54	Critical Outcome Technologies Inc. Provides Business Review and Update at Annual General Meeting
9/06 17:36	Critical Outcome Technologies Inc. Selected for Consulate General of Canada Life Sciences Partnering Mission